FDA Approves KRESLADI: First Gene Therapy for Rare, Life-Threatening Childhood Immune Disorder

The FDA has approved KRESLADI, Rocket Pharma’s one-time gene therapy for children with severe LAD-I — a rare, life-threatening immune disorder.